Showing results (811-820 of 945) with videos related to

Sort By:
Pageof 95
Diabetes, Obesity & Metabolism|November 6, 2018
Double-blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase-4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT-I StudyRonan Roussel, Santiago Duran-García, Yilong Zhang, et al.
Transplantation Direct|February 22, 2018
Pilot Study of Delayed ICOS/ICOS-L Blockade With αCD40 to Modulate Pathogenic Alloimmunity in a Primate Cardiac Allograft ModelNatalie A O'Neill, Tianshu Zhang, Gheorghe Braileanu, et al.
Experimental Eye Research|July 5, 2020
Intravitreal enzyme replacement preserves retinal structure and function in canine CLN2 neuronal ceroid lipofuscinosisRebecca E H Whiting, Jacqueline W Pearce, Daniella P Vansteenkiste, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 23, 2021
Pig-to-baboon lung xenotransplantation: Extended survival with targeted genetic modifications and pharmacologic treatmentsLars Burdorf, Christopher T Laird, Donald G Harris, et al.
The New England Journal of Medicine|April 13, 2000
Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant GroupE A Stadtmauer, A O'Neill, L J Goldstein, et al.
Plant Physiology|February 13, 2015
Galactose-depleted xyloglucan is dysfunctional and leads to dwarfism in ArabidopsisYingzhen Kong, Maria J Peña, Luciana Renna, et al.
Annals of Surgery|June 11, 1999
Clinical experience over 48 years with pheochromocytomaR E Goldstein, J A O'Neill, G W Holcomb, et al.
Vaccine|July 1, 2008
The safety and tolerability of an HIV-1 DNA prime-protein boost vaccine (DP6-001) in healthy adult volunteersJeffrey S Kennedy, Mary Co, Sharone Green, et al.
Biological Psychiatry|September 11, 2007
AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia familiesDawn L Thiselton, Vladimir I Vladimirov, Po-Hsiu Kuo, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 5, 2015
Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfismDaniel J Wendt, Melita Dvorak-Ewell, Sherry Bullens, et al.
Pageof 95